Friday, September 27, 2013

• ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Fri, Sep 27)
• Zalicus’ Z160 Receives Orphan Drug Designation for the Management of Postherpetic NeuralgiaBusiness Wire (Fri, Sep 27)

Friday, September 20, 2013

• Zalicus Is A Promising Biotech With Echoes Of Acadia Pharmaceuticalsat Seeking Alpha (Fri, Sep 20)

Monday, September 9, 2013

• ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon, Sep 9)
• Zalicus Initiates Phase 1b Clinical Study of Z944, Its Novel, Oral, T-type Calcium Channel Blocker, for the Treatment of PainBusiness Wire (Mon, Sep 9)

Tuesday, September 3, 2013

• Zalicus to Present at the Rodman & Renshaw 15th Annual Global Investment ConferenceBusiness Wire (Tue, Sep 3)
• Zalicus completes patient enrollment in two Z160 phase 2 studiestheflyonthewall.com (Tue, Sep 3)
• ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Tue, Sep 3)
• Zalicus Completes Patient Enrollment in Two Phase 2 Clinical Studies of Z160 for Chronic Neuropathic PainBusiness Wire (Tue, Sep 3)

Saturday, August 10, 2013

• ZALICUS INC. FinancialsEDGAR Online Financials (Sat, Aug 10)

Monday, August 5, 2013

• ZALICUS INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Mon, Aug 5)

Thursday, August 1, 2013

• For Zalicus, Z160 Data In October Could Be Hugeat Seeking Alpha (Thu, Aug 1)
• Zalicus Reports Financial Results for the Second Quarter 2013Business Wire (Thu, Aug 1)
• ZALICUS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Thu, Aug 1)

Wednesday, June 19, 2013

• Zalicus Publishes Data on Selective Estrogen Receptor Modulators for the Treatment of Infectious DiseaseBusiness Wire (Wed, Jun 19)
• ZALICUS INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Wed, Jun 19)

Thursday, June 6, 2013

• ZALICUS INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online (Thu, Jun 6)

Tuesday, June 4, 2013

• Zalicus Advancing Clinical Development of Z944, Its Novel, Oral, T-Type Calcium Channel Blocker, for the Treatment of PainBusiness Wire (Tue, Jun 4)
• ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Tue, Jun 4)

Wednesday, May 29, 2013

• Zalicus to Present at the Jefferies 2013 Global Healthcare ConferenceBusiness Wire (Wed, May 29)

Add ZLCS News to My Yahoo!